KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Acquisitions (2016 - 2019)

Abbott Laboratories' Acquisitions history spans 11 years, with the latest figure at $82.0 million for Q2 2019.

  • On a quarterly basis, Acquisitions rose 355.56% to $82.0 million in Q2 2019 year-over-year; TTM through Jun 2019 was $203.0 million, a 95.17% decrease, with the full-year FY2017 number at $17.2 billion, up 21378.75% from a year prior.
  • Acquisitions hit $82.0 million in Q2 2019 for Abbott Laboratories, up from $78.0 million in the prior quarter.
  • Over the last five years, Acquisitions for ABT hit a ceiling of $13.0 billion in Q1 2017 and a floor of $7.0 million in Q4 2016.
  • Historically, Acquisitions has averaged $2.0 billion across 5 years, with a median of $78.0 million in 2019.
  • Biggest five-year swings in Acquisitions: skyrocketed 59271.43% in 2017 and later crashed 99.81% in 2018.
  • Tracing ABT's Acquisitions over 5 years: stood at $231.0 million in 2015, then tumbled by 96.97% to $7.0 million in 2016, then skyrocketed by 59271.43% to $4.2 billion in 2017, then crashed by 99.57% to $18.0 million in 2018, then soared by 355.56% to $82.0 million in 2019.
  • Business Quant data shows Acquisitions for ABT at $82.0 million in Q2 2019, $78.0 million in Q1 2019, and $18.0 million in Q2 2018.